SCHEDULE 13G, AMENDMENT 1

Company

Finch Therapeutics Group, Inc.

Filed

February 14, 2022

Accession Number

0001014108-22-000050

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →